作者: David Krug , Rainer Souchon
DOI: 10.1159/000437452
关键词:
摘要: Ductal carcinoma in situ (DCIS) is a heterogeneous disease both its biology and clinical course. In the past, recurrence rates after breast-conserving surgery have been as high 30% 10 years. The introduction of mammography screening advances imaging led to an increase detection DCIS. focus this review on role radiotherapy multidisciplinary treatment, including current developments hypofractionation boost delivery, attempts define low-risk subsets DCIS for which need adjuvant radiation repeatedly questioned.